Atta and Pathak
1
silica gel to afford 20 (0.126 g, 48%). White gum, [R]26D +13.0 (c
Colorless oil, [R]26 +56.7 (c 0.10, CHCl3); H NMR (400 MHz,
D
1
0.2, CHCl3); H NMR (400 MHz, CDCl3) δ 1.67 (s, 3H), 2.40 (s,
CDCl3) δ 2.33(m, 1H), 2.38 (s, 3H), 3.66-3.70 (m, 2H), 3.75-3.80
(m, 5H), 3.93 (d, 1H, J ) 11.6 Hz), 4.14 (d, 1H, J ) 8.4 Hz),
4.19-4.24 (m, 3H), 4.50-4.59 (m, 5H), 6.69 (d, 2H, J ) 8.4 Hz),
6.88 (d, 2H, J ) 8.4 Hz), 6.97 (d, 2H, J ) 6 Hz), 7.12 (d, 2H, J
) 8 Hz), 7.16-7.34 (m, 13H), 7.71(d, 2H, J ) 8 Hz); 13C NMR
(100 MHz, CDCl3) δ 21.6, 30.3, 47.9, 55.2, 61.3, 63.9 (CH2), 71.6
(CH2), 72.6 (CH2), 73.1 (CH2), 73.5 (CH2), 73.7, 74.1 (CH2), 113.5,
127.1, 127.5, 127.6, 127.7, 127.8, 127.9, 128.1, 128.4, 128.5, 128.9,
129.2, 129.3, 129.5, 136.7, 137.1, 138.3, 138.6, 143.8, 159.2; HRMS
[ES+, (M + Na)+] for C42H44O7SNa obsd 715.2705, calcd 715.2693.
{(1S,2S,3R)-2-(1,2-Dibenzyloxyethyl)-3-benzyloxy-1-[(4-
methylphenyl)sulfonyl]cyclopropyl}methanol, 25. Compound 24
(0.09 g, 0.13 mmol) was converted to 25 (0.05 g, 71%) following
the procedure described for the preparation of 17. Colorless oil,
[R]26D +20.5 (c 0.11, CHCl3); 1H NMR (400 MHz, CDCl3) δ 2.30
(q, 1H, J ) 8.8, 10.0 Hz), 2.40 (s, 3H), 3.05 (d, 1H, J ) 9.2 Hz),
3.62-3.66 (m, 1H), 3.74-3.77 (m, 1H), 3.79-3.84 (m, 1H), 3.91
(d, 1H, J ) 13.6 Hz), 3.99-4.01 (m, 1H), 4.22 (d, 1H, J ) 11.2
Hz), 4.28 (d, 1H, J ) 8.4 Hz), 4.48 (d, 1H, J ) 11.2 Hz), 4.54-4.61
(m, 3H), 4.66 (d, 1H, J ) 11.2 Hz), 6.91 (d, 2H, J ) 6.4 Hz),
7.18-7.37 (m, 15H), 7.79 (d, 2H, J ) 8.4 Hz); 13C NMR (100
MHz, CDCl3) δ 21.6, 29.9, 49.3, 56.8 (CH2), 61.8, 70.5 (CH2),
71.2 (CH2), 72.6, 73.3 (CH2), 74.3 (CH2), 127.2, 127.5, 127.6, 127.7,
128.0, 128.1 (2 × C), 128.4, 128.5, 128.8, 129.6, 135.5, 136.4,
137.5, 137.9, 144.6; HRMS [ES+, (M + Na)+] for C34H36O6SNa
obsd 595.2102, calcd 595.2130.
3H), 2.46 (q, 1H, J ) 7.2, 15.0 Hz), 3.56-3.63 (m, 1H), 3.67-3.71
(m, 1H), 3.92 (d, 1H, J ) 15.6 Hz), 4.35 (d, 1H, J ) 7.6 Hz),
4.41-4.48 (m, 2H), 4.59-4.65 (m, 3H), 7.21 (d, 2H, J ) 6.4 Hz),
7.26-7.42 (m, 11H), 7.71 (d, 2H, J ) 8.4 Hz), 8.57 (s, 1H); 13C
NMR (100 MHz, CDCl3) δ 12.3, 21.7, 28.0, 40.2 (CH2), 45.6, 61.1,
62.6 (CH2), 73.1 (CH2), 74.2 (CH2), 110.4, 127.7, 127.9, 128.1,
128.4, 128.5, 128.6, 128.8, 129.9, 135.4, 135.9, 137.4, 139.6, 145.3,
151.2, 163.7; HRMS [ES+, (M + H)+] for C31H33N2O6S obsd
561.2056, calcd 561.2059.
(1R,2R,3S)-2-Benzyloxy-3-(benzyloxymethyl)-1-methylcyclo-
propyl 4-Methylphenyl Sulfone, 21. To a well-stirred solution of
6 (0.10 g, 0.187 mmol) in dry MeOH (10 mL) was added NaBH4
(0.07 g, 1.87 mmol) and the mixture was stirred at ambient
temperature under N2. After 1 h, MeOH was evaporated to dryness
under reduced pressure, and the residue was dissolved in an aq
saturated solution of NaHCO3 and the product was extracted with
EtOAc (3 × 10 mL). The combined organic layer was dried over
anhyd Na2SO4 and concentrated under reduced pressure to afford
a residue. A solution of the crude material in DMF (10 mL) was
treated with NaH (0.02 g, 0.37 mmol) for 1 h. Then the reaction
mixture was poured into an aq saturated solution of NaHCO3 and
the product was extracted with EtOAc (3 × 10 mL). The combined
organic layer was dried over anhyd Na2SO4 and concentrated under
reduced pressure to afford a residue. The residue was purified over
silica gel to afford 21 (0.04 g, 50%). Colorless oil, [R]27D +63.8 (c
0.08, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.31 (s, 3H), 2.28 (q,
1H, J ) 14 Hz), 2.43 (s, 3H), 3.44-3.54 (m, 1H), 3.62-3.71 (m,
1H), 4.15 (d, 1H, J ) 16 Hz), 4.34-4.51 (m, 4H), 7.14-7.19 (m,
2H), 7.26-7.36 (m, 10H), 7.75 (d, 2H, J ) 16.4 Hz); 13C NMR
(100 MHz, CDCl3) δ 7.2, 21.7, 26.2, 43.7, 60.6, 63.4 (CH2), 72.5
(CH2), 73.8 (CH2), 127.4, 127.5, 127.9, 128.1, 128.3, 128.5, 128.7,
129.7, 135.3, 136.7, 138.1, 144.3; HRMS [ES+, (M + Na)+] for
C26H28O4SNa calcd 459.1582, obsd 459.1606.
(1R,2S,3R)-2-(1,2-Dibenzyloxyethyl)-3-benzyloxy-1-[(methyl-
sulfanyl)methyl]cyclopropyl 4-Methylphenyl Sulfone, 26. Com-
pound 12 (0.30 g, 0.46 mmol) was converted to 26 (0.16 g, 56%)
following the procedure described for the preparation of 18.
1
Colorless oil, [R]24 +15.3 (c 0.04, CHCl3); H NMR (400 MHz,
D
CDCl3) δ 1.94 (s, 3H), 2.37 (t, 1H, J ) 8.8 Hz), 2.46 (s, 3H),
2.75-2.83 (m, 2H), 3.65-3.70 (m, 2H), 3.78-3.81 (m, 1H), 4.21
(d, 1H, J ) 8.8 Hz), 4.37 (d, 1H, J ) 11.2 Hz), 4.57-4.65 (m,
4H), 4.80 (d, 1H, J ) 11.6 Hz), 7.02-7.04 (m, 2H), 7.20-7.37
(m, 15H), 7.85 (d, 2H, J ) 8.4 Hz); 13C NMR (100 MHz, CDCl3)
δ 17.9, 21.7, 29.0 (CH2), 31.1, 47.3, 61.2, 71.4 (CH2), 72.1 (CH2),
73.0, 73.4 (CH2), 74.4 (CH2), 127.3, 127.6, 127.7, 128.0, 128.4,
128.5, 128.9, 129.5, 135.7, 136.8, 138.1, 138.4, 144.4; HRMS [ES+,
(M + Na)+] for C35H38O5S2Na obsd 625.2031, calcd 625.2058.
(1R,2S,3R)-2-(1,2-Dibenzyloxyethyl)-3-benzyloxy-1-[(benzyl-
sulfanyl)methyl]cyclopropyl 4-Methylphenyl Sulfone, 27. To a
well-stirred solution of benzylthiol (0.20 mL, 1.53 mmol) and TMG
(0.10 mL, 0.918 mmol) in DMF (10 mL) was added 12 (0.10 g,
0.153 mmol) and the mixture was stirred at ambient temperature
under N2. After 3 h, the reaction mixture was poured into an aq
saturated solution of NH4Cl and the product was extracted with
EtOAc (3 × 10 mL). The combined organic layer was dried over
anhyd Na2SO4 then filtered, and the filtrate was concentrated under
reduced pressure to afford a residue. The residue was purified over
silica gel to afford 27 (0.05 g, 49%). Colorless oil, [R]26D +63.3 (c
0.05, CHCl3); 1H NMR (400 MHz, CDCl3) δ 2.29-2.34 (m, 1H),
2.43 (s, 3H), 2.64 (d, 1H, J ) 13.6 Hz), 2.81 (d, 1H, J ) 14 Hz),
3.51 (s, 3H), 3.58-3.62 (m, 1H), 3.71 (d, 1H, J ) 10.4 Hz), 4.15-
4.21 (m, 2H), 4.51-4.60 (m, 4H), 4.68 (d, 1H, J ) 11.6 Hz), 6.94
(d, 2H, J ) 7.2 Hz), 7.07 (br s, 2H), 7.15-7.33 (m, 18H), 7.76 (d,
2H, J ) 7.6 Hz); 13C NMR (100 MHz, CDCl3) δ 21.7, 25.9 (CH2),
31.2, 38.2 (CH2), 46.8, 61.2, 71.5 (CH2), 71.9 (CH2), 73.2, 73.3
(CH2), 74.3 (CH2), 126.9, 127.2, 127.4, 127.6, 127.8, 127.9, 128.0,
128.3 (2 × C), 128.4, 128.7, 128.9, 129.4, 135.4, 136.7, 137.7,
138.1, 138.3, 144.2; HRMS [ES+, (M + Na)+] for C41H42O5S2Na
obsd 701.2372, calcd 701.2371.
2-{[(1S,2S,3R)-2-(1,2-Dibenzyloxyethyl)-3-benzyloxy-1-(4-meth-
ylphenylsulfonyl)cyclopropyl]methyl}-1H-isoindole-1,3(2H)-di-
one, 22. Compound 12 (0.40 g, 0.61 mmol) was converted to 22
(0.22 g, 52%) following the procedure described for the preparation
1
of 13. Colorless oil, [R]26 +52.3 (c 0.11, CHCl3); H NMR (400
D
MHz, CDCl3) δ 2.31 (s, 3H), 2.49 (q, 1H, J ) 8.8, 10.4 Hz),
3.67-3.71 (m, 1H), 3.82-3.85 (m, 1H), 3.94-4.01 (m, 2H), 4.32
(d, 1H, J ) 8.8 Hz), 4.43 (d, 1H, J ) 14.8 Hz), 4.52 (d, 1H, J )
11.2 Hz), 4.61 (q, 2H, J ) 12.4 Hz), 4.72-4.80 (m, 2H), 5.08 (d,
1H, J ) 11.6 Hz), 7.02 (d, 2H, J ) 8 Hz), 7.24-7.38 (m, 15H),
7.65-7.67 (m, 4H), 7.70-7.72 (m, 2H); 13C NMR (100 MHz,
CDCl3) δ 21.6, 29.3, 31.4 (CH2), 42.9, 61.7, 71.2 (CH2), 71.7 (CH2),
72.4, 73.4 (CH2), 74.2 (CH2), 123.1, 127.4, 127.7, 127.8, 127.9,
127.9, 128.1, 128.2, 128.4, 128.5, 129.5, 132.1, 133.8, 136.1, 137.2,
138.1, 138.2, 144.1, 167.5; HRMS [ES+, (M + Na)+] for
C42H39NO7SNa obsd 724.2348, calcd 724.2345.
(1S,2S,3R)-2-(1,2-Dibenzyloxyethyl)-3-benzyloxy-1-(methoxy-
methyl)cyclopropyl 4-Methylphenyl Sulfone, 23. Compound 12
(0.20 g, 0.30 mmol) was converted to 23 (0.08 g, 46%) following
the procedure described for the preparation of 15. Colorless oil,
[R]24D +48.9 (c 0.21, CHCl3); 1H NMR (400 MHz, CDCl3) δ 2.29
(t, 1H, J ) 9.2 Hz), 2.43 (s, 3H), 3.08 (s, 3H), 3.62-3.72 (m, 3H),
3.75-3.83 (m, 2H), 4.13 (d, 1H, J ) 8.4 Hz), 4.28 (d, 1H, J )
11.2 Hz), 4.47 (d, 1H, J ) 11.6), 4.54-4.63 (m, 4H), 7.04-7.07
(m, 2H), 7.20-7.38 (m, 15H), 7.77 (d, 2H, J ) 8 Hz); 13C NMR
(100 MHz, CDCl3) δ 21.6, 30.2, 47.9, 58.5, 61.2, 66.1 (CH2), 71.6
(CH2), 72.6 (CH2), 73.4 (CH2), 73.5, 74.0 (CH2), 127.2, 127.5,
127.6, 127.8, 127.9, 128.0, 128.3, 128.4, 128.9, 129.2, 136.6, 136.8,
138.2, 138.5, 143.9; HRMS [ES+, (M + Na)+] for C35H38O6SNa
obsd 609.2282, calcd 609.2287.
1-{[(1S,2S,3R)-2-(1,2-Dibenzyloxyethyl)-3-benzyloxy-1-(4-meth-
ylphenyl sulfonyl)cyclopropyl]methyl}-5-methylpyrimidine-2,4(1H,
3H)-dione, 28. Compound 12 (0.25 g, 0.38 mmol) was converted
to 28 (0.12 g, 46%) following the procedure described for the
preparation of 20. Colorless oil, [R]24D -72.4 (c 0.04, CHCl3); 1H
NMR (400 MHz, CDCl3) δ 1.69 (s, 3H), 2.37 (s, 3H), 2.40-2.42
(1S,2S,3R)-2-(1,2-Dibenzyloxyethyl)-3-benzyloxy-1-{[(4-meth-
oxybenzyl)oxy]methyl}cyclopropyl 4-Methylphenyl Sulfone, 24.
Compound 12 (0.30 g, 0.46 mmol) was converted to 24 (0.18 g,
57%) following the procedure described for the preparation of 16.
2716 J. Org. Chem. Vol. 74, No. 7, 2009